Tokyo Tape
Sign in
← Nippon Kayaku

Quarterly report · Q1

4272.TEDINET S100RJ1O
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥198.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥2.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥4.2bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥23.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥4.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥343.0bnat 2023-06-30Cons.Assets
Total assets¥322.9bnat 2023-03-31Cons.Assets
Total assets¥325.4bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥79.5bnat 2023-06-30Cons.Liabilities
Total liabilities¥67.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥263.5bnat 2023-06-30Cons.Net assets
Net assets / equity¥255.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.2bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥48.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥16.062023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.042023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥89.332022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥9m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥9m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.0bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥14.0bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥13.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥9m
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥15.4bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥15.4bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥19.3bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥19.3bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-06-30¥48.6bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥48.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥9m
—segment totalsegment profit2023-04-01 → 2023-06-30¥4.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥51m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥51m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥16.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥16.8bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥14.8bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥14.8bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥16.7bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥16.7bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥8m
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.9bn
—segment totalrevenue2022-04-01 → 2022-06-30¥48.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥51m
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 376
ItemContextValueUnit
Loss on valuation of investment securities elCurrentYTDDuration765000000JPY
Extraordinary lossPrior1YTDDuration136000000JPY
Extraordinary lossCurrentYTDDuration949000000JPY
Income before income taxesPrior1YTDDuration8526000000JPY
Income before income taxesCurrentYTDDuration4155000000JPY
Income taxes currentPrior1YTDDuration1480000000JPY
Income taxes currentCurrentYTDDuration905000000JPY
Income taxes deferredPrior1YTDDuration1072000000JPY
Income taxes deferredCurrentYTDDuration569000000JPY
Income taxesPrior1YTDDuration2552000000JPY
Income taxesCurrentYTDDuration1475000000JPY
Profit lossPrior1YTDDuration5973000000JPY
Profit lossCurrentYTDDuration2679000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration16000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration18000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration5957000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2661000000JPY
Profit lossPrior1YTDDuration5973000000JPY
Profit lossCurrentYTDDuration2679000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-924000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration3383000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration5371000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration6719000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-86000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-17000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration0JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration0JPY
Other comprehensive incomePrior1YTDDuration4361000000JPY
Other comprehensive incomeCurrentYTDDuration10085000000JPY
Comprehensive incomePrior1YTDDuration10334000000JPY
Comprehensive incomeCurrentYTDDuration12765000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration10249000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration12681000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration85000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration84000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember16694000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember16808000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember14794000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember48296000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration48296000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember8000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember42000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember0JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember51000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-51000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember16703000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember16850000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember14794000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass